The buyers, the partners, and the companies you’ve been trying to reach will all be in one building this May.
Three days. 2,000+ attendees. The partnering app lets you book meetings before you arrive.
Founders on Stage
Investors & Funders Confirmed
Why People Keep Coming Back
"SynBioBeta is an incredible meeting place. I met BitBiome there, and we ended up using their amazing technology to find enzymes that we're now engineering into new strains for new products. I wouldn't have made this connection and collaboration without attending SynBioBeta."
"SynBioBeta is an incredible meeting place. I met BitBiome there, and we ended up using their amazing technology to find enzymes that we're now engineering into new strains for new products. I wouldn't have made this connection and collaboration without attending SynBioBeta."
Zack Abbott
Founder & CEO, ZBiotics
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
Luis Cascao-Pereira
Head of Digital Biology, IFF
"SynBioBeta creates the kind of environment where real collaborations start. That's where I met the team at IFF, and the conversation quickly turned into a project to improve one of their enzymes."
"SynBioBeta creates the kind of environment where real collaborations start. That's where I met the team at IFF, and the conversation quickly turned into a project to improve one of their enzymes."
Matthew Thompson
VP Industrial Biotech, Biomatter
1
•
-
Tools & Tech
From AI protein design to real-world commercial impact: powering the next wave of everyday products
For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.
Register Now
1
•
-
Tools & Tech
From AI protein design to real-world commercial impact: powering the next wave of everyday products
For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.
Register Now
2
•
-
Tools & Tech
Engineering Resilient Pharma Supply Chains with Biology
For decades, pharmaceutical supply chains were optimized for cost and scale, stretching across continents to source critical active ingredients. But fragility has made resilience a strategic imperative. Synthetic biology offers a new model: onshoring the production of essential APIs by programming cells to manufacture small molecules, peptides, and novel amino acids with precision and scalability. Instead of relying on distant chemical supply networks, biology becomes the factory—flexible, distributed, and programmable. This session explores how engineered microbes and directed evolution platforms are rebuilding pharma supply chains from the molecular level up, enabling secure, responsive, and locally anchored production of the medicines the world depends on.
Register Now
Featuring
Ola Wlodek
Constructive Bio
CEO
Leader in Non-Canonical Amino Acids and genome design
Christina Smolke
Antheia
CEO & Co-Founder
Synthetic-biology pioneer decoupling medicines from fragile supply chains.
Tina Boville
Aralez Bio
Co-founder & CEO
Enzyme engineer expanding peptide chemistry’s noncanonical frontier.
2
•
-
Tools & Tech
Engineering Resilient Pharma Supply Chains with Biology
For decades, pharmaceutical supply chains were optimized for cost and scale, stretching across continents to source critical active ingredients. But fragility has made resilience a strategic imperative. Synthetic biology offers a new model: onshoring the production of essential APIs by programming cells to manufacture small molecules, peptides, and novel amino acids with precision and scalability. Instead of relying on distant chemical supply networks, biology becomes the factory—flexible, distributed, and programmable. This session explores how engineered microbes and directed evolution platforms are rebuilding pharma supply chains from the molecular level up, enabling secure, responsive, and locally anchored production of the medicines the world depends on.
Register Now
Featuring
Ola Wlodek
Constructive Bio
CEO
Leader in Non-Canonical Amino Acids and genome design
Christina Smolke
Antheia
CEO & Co-Founder
Synthetic-biology pioneer decoupling medicines from fragile supply chains.
Tina Boville
Aralez Bio
Co-founder & CEO
Enzyme engineer expanding peptide chemistry’s noncanonical frontier.
3
•
-
Biomanufacturing
Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS
Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.
Register Now
Featuring
Jamie Bacher
Huxley Project
Principal
Ag-biotech veteran guiding tech to market.
Colby Adolph
Evonik
Sales Director
Fermentation scale-up connector: turning prototypes into manufacturable reality
Ling Li
ADM
Dir. Market Dev., Prec. Ferm.
Precision fermentation dealmaker bridging startups, scale, and brands
Eric Lee
Primient
Director, B&D - Fermentation
3
•
-
Biomanufacturing
Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS
Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.
Register Now
Featuring
Jamie Bacher
Huxley Project
Principal
Ag-biotech veteran guiding tech to market.
Colby Adolph
Evonik
Sales Director
Fermentation scale-up connector: turning prototypes into manufacturable reality
Ling Li
ADM
Dir. Market Dev., Prec. Ferm.
Precision fermentation dealmaker bridging startups, scale, and brands
Eric Lee
Primient
Director, B&D - Fermentation
4
•
-
CEO's Luncheon
This invitation-only luncheon convenes CEOs and founders from across the synthetic biology and biotechnology ecosystem for a candid, peer-level conversation. Designed as an intimate gathering, the session offers a chance to step away from the main stage and connect with fellow leaders navigating the opportunities and challenges of building and scaling companies in this rapidly evolving field. Join us for thoughtful discussion, shared insights, and meaningful connections with other executives shaping the future of the bioeconomy. Please note: Conference registration is required to attend this event. If you haven't registered yet, secure your spot at https://www.syntheticbiologysummit.com/
Register Now
Featuring
Speaker Coming Soon
4
•
-
CEO's Luncheon
This invitation-only luncheon convenes CEOs and founders from across the synthetic biology and biotechnology ecosystem for a candid, peer-level conversation. Designed as an intimate gathering, the session offers a chance to step away from the main stage and connect with fellow leaders navigating the opportunities and challenges of building and scaling companies in this rapidly evolving field. Join us for thoughtful discussion, shared insights, and meaningful connections with other executives shaping the future of the bioeconomy. Please note: Conference registration is required to attend this event. If you haven't registered yet, secure your spot at https://www.syntheticbiologysummit.com/
Register Now
Featuring
Speaker Coming Soon
